Definitions for "Cost recovery"
A legal process where potentially responsible parties can be required to pay back the federal or state government for money spent on cleanup actions. Cost recovery actions usually begin after the government has completed a site cleanup.
user pays for specific services provided by the public veterinary services by virtue of their responsibility.
The degree to which the costs of water supply and sanitation services are paid for by the users. Includes two categories of costs: the initial investment costs and the continuous cost of operation and maintenance. The basic cost recovery principle requires that 100 percent of operation and maintenance costs be covered by the users. As for the initial investment costs, users are usually required to pay a part of them, possibly through in-kind contributions made by the parents.
Writing off the capitalized cost of "wasting assets" (those that lose value over time because of wear and tear, physical deterioration, or obsolescence, and that have a reasonably ascertainable useful life) over their estimated useful lives. This has the effect of deducting the total cost of an asset over the years in which it is used to help generate revenue for the taxpayer. Land and works of art acquired for display are not subject to such income tax treatment.
Formerly known as "depreciation" for tax purposes is the systematic calculated reduction in value of a property's improvements to reflect wear and tear, and obsolescence. The calculated amount of cost recovery is deducted from the Net Operating Income of an investment property to determine taxable income and reduces the Basis which determines the taxable gain at sale. See Basis & Recapture.
The ratio between fare revenue and operating costs.
Where the agency is fully funded from administrative fees levied on industry. D-F
Fee structures to cover the cost of providing a service.
Fee structures that cover the cost of providing the service or investment.
a program under which drug companies are paid to provide a new drug at the expanded access stage, before marketing approval has been granted.